Back to search

France· FR:65599882

SPINRAZA 12 mg, solution injectable

A nusinersen product containing nusinersen sodique, registered in France by BIOGEN NETHERLANDS (PAYS-BAS). The same ATC class is registered in 13 of our 19 countries.

ATC M09AX07

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSPINRAZA 12 mg, solution injectableATCM09AX07REGISTER NO.FR:65599882PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Nusinersen is registered in 13 of 19 countries.

Countries holding a registration under ATC M09AX07 (nusinersen), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Nusinersen · ATC M09AX07

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nusinersen costs, country by country.

Normalised to the WHO defined daily dose (0.1 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Nusinersen · price per daily dose (0.1 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$531.69
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
NUSINERSEN SODIQUE
Manufacturer
BIOGEN NETHERLANDS (PAYS-BAS)
Country
France (FR)
ATC code
M09AX07
ATC class
Nusinersen
Defined daily dose
0.1 mg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955033158
    1 flacon(s) en verre de 5 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Nusinersen in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nusinersen products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Spinraza
  • Liechtenstein · Spinraza
  • Norway · Spinraza

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0c8636d8-0aac-4ad1-91c9-a008e5e0584d
GET /v1/drugs/0c8636d8-0aac-4ad1-91c9-a008e5e0584d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65599882",
  "date_amm": "2017-05-30",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/17/1188",
  "substance": "NUSINERSEN SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intrathécale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about nusinersen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.